The duration of follow-up varied across the studies, spanning from 12 to 48 months, with an average follow-up duration of 27.5 months
(2023): Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes
If you have a high BMI (over 30) and want to achieve a healthy weight for your height (a BMI of 18.5-24.9), then its often best to set smaller goals along the way, such as a 5% or 10% loss of your initial starting weight
While companies are beginning to catch up with the demand for these drugs, some shortages still remain
For context, Ozempic, which contains the same semaglutide molecule but is FDA-approved for type 2 diabetes, remained covered under diabetes indications
Research-grade products vary by supplier